Efficacy and safety of oxaliplatin and capecitabine in combination with sintilimab as first-line treatment for HER2-negative advanced gastric cancer
"<b>Objective</b> To analyze the clinical efficacy and the occurrence of adverse events of the oxaliplatin and capecitabine (XELOX) combined with sintilimab as a first-line treatment in patients with human epidermal growth factor receptor2 (HER2)-negative advanced gastric cancer(GC). <b>Methods</b...
Gorde:
| Egile nagusia: | |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Chinês |
| Argitaratua: |
The Editorial Department of Chinese Journal of Clinical Research
2025-01-01
|
| Saila: | Zhongguo linchuang yanjiu |
| Gaiak: | |
| Sarrera elektronikoa: | http://zglcyj.ijournals.cn/zglcyj/ch/reader/create_pdf.aspx?file_no=20250108&year_id=2025&quarter_id=1&falg=1 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|